Influence of Age on the Intravenous Tolbutamide Response Test

Author:

Swerdloff Ronald S1,Pozefsky Thomas1,Tobin Jordan D1,Andres Reubin1

Affiliation:

1. Gerontology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Public Health Service, U.S. Department of Health, Education Welfare, Bethesda Department of Medicine, Baltimore City Hospitals, and Department of Medicine, The Johns Hopkins University Baltimore, Maryland

Abstract

Intravenous tolbutamide response tests were performed on a selected group of 100 community-dwelling volunteer male subjects aged twenty-one to eighty-one years. A deterioration in performance with age was manifest as a progressively lesser fall and later nadir of blood glucose concentration throughout the early adult years and middle age. There was no further decrease in response after the sixth decade of life. Many investigations of the tolbutamide response test have been reported since the standards of normality for the test were introduced eight years ago. Those studies, in addition to the present report, show that the application of these standards to diverse population groups results in a very high percentage of “abnormal” or “diabetic” responses. We have considered the reasons for the large variation in response to intravenous tolbutamide reported in the literature. It appears that studies which report relatively large responses to tolbutamide are those in which the subject group was (a) composed predominantly of young adults, or (b) preselected on the basis of superior performance on glucose tolerance tests, or both. Data derived from this type of selection procedure provide standards of normality which are not applicable to the general population. We therefore propose a new approach to the interpretation of the results on the tolbutamide test: A set of nomograms is provided which permits the rapid computation of ageadjusted percentile ranking of an individual's response to intravenous tolbutamide.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3